— PHENPath.com helps Prostate Cancer patients understand their treatment pathways and treatment options. Prostate Cancer diagnosis, Treatment Options, PSA Recurrence after Radical Prostatectomy, Progression After Radiation, Hormone Sensitive Cancer, Castration Resistent Cancer, Low Risk, Very Low Risk, Intermediate Risk, High Risk, Very High Risk, Metastatic, Regional, Prostate Cancer Diagnosis, Testing, Treatment Therapies, Understanding your Risk Level
As part of the Jackson, MS Disparity Rally, Dr. Timothy Quinn, the Medical Director of Quinn Healthcare, explains the importance of early prostate cancer detection to save lives. Dr. Quinn advises men to visit PHENPath.com for information on the latest prostate cancer treatments.
#ProstateCancer #CancerTreatments #ProstateCancerAwareness #CancerScreening #ProstateCancerDetection #Jackson #Mississippi #ProstateCancerDisparity #DisparityRally #PHEN
The Jackson, Mississippi Prostate Cancer Disparity Rally mobilized leaders to record prostate cancer awareness messages.
PHENPath.com – Empowering Patients
PHEN Supports Talapro-3 Clinical Trial
The FDA approves a new prostate cancer combination treatment based upon a successful clinical trial
If you are experiencing PSA recurrence after surgery, PHENPath.com provides information about available treatment options as set forth by NCCN Guidelines娩2020-2024 Prostate Health Education Network, Inc. All Rights Reserved.
Supported by:
